GABRIELLE PLACIDE: Open Payments
NPI 1245450345 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 24 payments from 8 companies in 2025. Trend: 2023 $1,990 · 2024 $3,414 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $663 |
| ViiV Healthcare Company | 7 | $317 |
| ABBVIE INC. | 1 | $150 |
| Merck Sharp & Dohme LLC | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 1 | $42 |
| Lundbeck LLC | 1 | $33 |
| Exact Sciences Corporation | 1 | $25 |
Products named: Biktarvy, DOVATO, MAVYRET, Yeztugo, Descovy, PIFELTRO, UZEDY, CABENUVA.
Industry payments across DC — which companies pay providers there.
